Overview & Mechanism
Binds the ghrelin (GHS) receptor to strongly stimulate GH release; also exhibits direct cardioprotective effects independent of GH.
Research Dosage
1–2 mcg/kg per dose
Subcutaneous injection
1–3 times daily
4–8 weeks
Reconstitution & Storage
Reconstitute a 2 mg vial with 2 mL of bacteriostatic water (1 mg/mL).
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.
Safety & Side Effects
May cause mild cortisol/prolactin elevation and transient head rush. Avoid food 1 hour before/after.
Studies
Hexarelin GH and cardiac effects
Hexarelin induced strong GH release and demonstrated cardioprotective effects in animal models of ischemia, independent of GH.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.